Efficacy of Various Aerobic Exercises on Abdominal Obesity in Women With Metabolic Syndrome.

NCT03445741 | Completed DMC

• 1 other identifier: 2015TPF037
• Study Type: interventional
• Target: 60
• Locations: 0 countries
• Sites: N/A

Brief Summary

Objective: To show metabolic and hormonal responses and effects on abdominal obesity of aerobic exercise in different intensity and duration and detraining period in women with metabolic syndrome.

Conditions

Metabolic Syndrome

Keywords

Aerobic exercise; Metabolic syndrome; Pedometer

Outcome Measures

Primary Outcomes (7)

• *Change from baseline in abdominal viseral fat and trunk fat and measured by VIScan at week 12 and 4-week detraining period.

  BIA device ViScan, designed to estimate visceral adiposity and trunk fat percentage. A wireless 'electrode belt' is placed on the bare midriff of the subject in supine position. The belt then uses dual frequency bio impedance (6.25 and 50 kHz) to measure trunk and visceral fat resistance and transmit the readings via infrared to the base unit.

  Week 12 and week 16

• *Change from baseline in weight (kilograms) at week 12 and 4- week detraining period.

  Weight was measured with weight scale.

  Week 12 and week 16

• *Change from baseline in Epinephrine/Adrenaline parameter at week 12 and 4- week detraining period.

  Fasting blood samples were collected at morning hours before exercise testing. To perform adrenaline values, a sum of blood were stored at -80 C for later study.

  Week 12 and week 16

• *Change from baseline in noradrenaline parameter at week 12 and 4- week detraining period.

  Fasting blood samples were collected at morning hours before exercise testing. To perform noradrenaline values, a sum of blood were stored at -80 C for later study.

  Week 12 and week 16

• *Change from baseline in free fatty acide parameter at week 12 and 4- week detraining period.

  Fasting blood samples were collected at morning hours before exercise testing. To perform free fatty acide values, a sum of blood were stored at -80 C for later study.

  Week 12 and week 16

• *Change from baseline in oxyntomodulin parameter at week 12 and 4- week detraining period.

  Fasting blood samples were collected at morning hours before exercise testing. To perform oxyntomodulin values, a sum of blood were stored at -80 C for later study.

  Week 12 and week 16

• *Change from baseline in glycerol parameter at week 12 and 4- week detraining period.

  Fasting blood samples were collected at morning hours before exercise testing. To perform glycerol values, a sum of blood were stored at -80 C for later study.

  Week 12 and week 16

Study Arms (3)

Supervised treadmill group (%70 VO2 max)

ACTIVE COMPARATOR

Supervised treadmill group (%70 VO2 max) (group 1): The participants were instructed walking exercise at their target heart rate, (% 70 of maximum oxygen consumption) on a treadmill in Sports Rehabilitation Unit of Pamukkale University.

Other: Supervised treadmill group (%70 VO2 max) (group 1)

Supervised treadmill group (%50 VO2 max)

EXPERIMENTAL

Supervised treadmill group (%50 VO2 max) (group 2): The participants were instructed walking exercise at their target heart rate, (% 50 of maximum oxygen consumption) on a treadmill in Sports Rehabilitation Unit of Pamukkale University.

Other: Supervised treadmill group (%50 VO2 max) (group 2)

ECE PEDO pedometer group (%50 VO2 max)

EXPERIMENTAL

ECE PEDO pedometer group (%50 VO2 max) (group 3): The participants were instructed walking with ECE PEDO which the number of steps taken in a minute corresponding to target HR at % 50 of maximum oxygen consumption were provided.

Device: ECE PEDO pedometer group (%50 VO2 max) (group 3)

Interventions

Supervised treadmill group (%70 VO2 max) (group 1) OTHER

An exercise prescription was developed for each woman on the basis of the data acquired from the baseline treadmill exercise test. Target heart rate (HR) corresponding to values of 70% VO2max were determined by the submaximal treadmill test. The participants were instructed walking at their target HR on a treadmill in Sports Rehabilitation Unit of Pamukkale University. HR was monitored by a Polar HR monitor (Polar Beat, Port, Washington, NY). During 12 weeks, 3 days in a week and 20 minutes per day walking program was applied.

Supervised treadmill group (%70 VO2 max)

Supervised treadmill group (%50 VO2 max) (group 2) OTHER

An exercise prescription was developed for each woman on the basis of the data acquired from the baseline treadmill exercise test. Target heart rate (HR) corresponding to values of 50% VO2max were determined by the submaximal treadmill test. The participants were instructed walking at their target HR on a treadmill in Sports Rehabilitation Unit of Pamukkale University. HR was monitored by a Polar HR monitor (Polar Beat, Port, Washington, NY). During 12 weeks, 5 days in a week and 30 minutes per day walking program was applied.

Supervised treadmill group (%50 VO2 max)

ECE PEDO pedometer group (%50 VO2 max) (group 3) DEVICE

Target heart rate (HR) corresponding to values of 50 % VO2max were determined by the submaximal treadmill test. The number of steps taken in a minute corresponding to target HR was determined by a criterion pedometer and group 3 was instructed walking in this step range recorded to ECE PEDO giving audible feedback. During 12 weeks, 5 days in a week and 30 minutes per day walking program was applied.

ECE PEDO pedometer group (%50 VO2 max)

Eligibility Criteria

• Age: 25 Years - 65 Years
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants were well communicative, motivated and willing to participate in the study.

Sponsors & Collaborators

• Pamukkale University: lead

MeSH Terms

Conditions

Metabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin Resistance; Hyperinsulinism; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor M.D.

Model Details: Participants are assigned to three groups in parallel for the duration of the study.

Study Record Dates

• First Submitted: February 11, 2018
• First Posted: February 26, 2018
• Study Start: August 1, 2016
• Primary Completion: April 1, 2018
• Study Completion: June 1, 2018
• Last Updated: August 29, 2018

Record last verified: 2018-08